San Diego, CA -- (SBWIRE) -- 03/20/2023 -- An investigation was announced for investors of Disc Medicine Opco Inc (NASDAQ: IRON) shares over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Disc Medicine Opco Inc (NASDAQ: IRON), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Disc Medicine Opco Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On February 8, 2021, Gemini Therapeutics announced the completion of its business combination with FS Development Corp., a special purpose acquisition company (SPAC) sponsored by Foresite Capital. Gemini Therapeutics, the resulting combined company, commenced trading its shares on February 8, 2021, on the Nasdaq Global Market under the symbol "GMTX."

Then on August 10, 2022, Gemini Therapeutics, Inc. (Nasdaq: GMTX) and Disc Medicine, Inc. , a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases, announced that they have entered into a merger agreement to combine the companies in an all-stock transaction.

On December 29, 2022, Disc Medicine, Inc. announced that its merger with Gemini Therapeutics, Inc. ("Gemini") closed on December 29, 2022. Its shares commenced trading on a 1-10 reverse split adjusted basis effective with the open of business on December 30, 2022 on the Nasdaq Global Market under the ticker symbol IRON.

Shares of Disc Medicine Opco Inc (NASDAQ: IRON) declined from $55.50 per share on June 24, 2022, to as low as $15.00 per share on December 30, 2022.

Those who purchased shares of Disc Medicine Opco Inc (NASDAQ: IRON) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.